This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top-Ranked Health Care Companies Delivering Steady Growth
by David Borun
These firms are aggressively managing costs and benefit from a demographic shift in health care spending
Grab These 8 Stocks for Their Strong Numbers
by Sejuti Banerjea
These companies have reported solid results, leading analysts to raise estimates.
Zacks.com highlights: athenahealth, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Commvault Systems, Molina Healthcare and Fortinet
4 Top Liquid Stocks for a Winning Portfolio
by Zacks Equity Research
Here are four marvelous liquid stocks that investors should snap up now for stellar returns.
4 Attractive Health Insurers From a Top-Ranked Industry
by Sapna Bagaria
Health insurers are poised for growth on strong demand, new business, use of technology and revenue diversification
5 Sizzling Stocks Played Down by Hedge Funds in Q2
by Aniruddha Ganguly
We pick five large cap top-ranked stocks that have been ignored by hedge funds in Q2.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina Healthcare (MOH) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for MOH for clues.
Molina Healthcare Hits 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare (MOH) stock gains as its restructuring initiatives start bearing fruit.
Zacks.com featured highlights include: United States Cellular, Molina Healthcare, Archer Daniels, Bristol-Myers and Callaway Golf
by Zacks Equity Research
Zacks.com featured highlights include: United States Cellular, Molina Healthcare, Archer Daniels, Bristol-Myers and Callaway Golf
Pick These 5 Stocks With Remarkable Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Bet on 5 Stocks With Strong Earnings Beat Prospects
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
Trump Boosts Short-Term Health Plans: Top 4 Insurance Plays
by Nitish Marwah
Trump's latest push to provide an alternative to the ACA would provide millions of Americans the freedom to choose their own health policies.
Value Stocks Outperforming Growth: 5 Top Picks
by Sweta Killa
The long overlooked corner of the broad stock market - value investing - has started to gain momentum lately amid escalating trade tensions and an aging bull market.
New Strong Buy Stocks for August 6th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Molina Healthcare (MOH) Tops Q2 Earnings, Updates '18 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 gains from a decline in expense. The company also revises its full-year guidance.
Molina (MOH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 106.42% and 4.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Revenue Growth Drive Teladoc (TDOC) Q2 Earnings Higher?
by Zacks Equity Research
Teladoc (TDOC) Q2 earnings to gain from increased patient visits and subscription fees.
Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance
by Zacks Equity Research
Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.
Anthem (ANTM) Q2 Earnings: Is a Beat in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings are likely to gain from the solid performance of its Government Business and Commercial & Specialty Business segments.
UnitedHealth's (UNH) Q2 Earnings Beat, 2018 Guidance Up
by Zacks Equity Research
UnitedHealth (UNH) Q2 earnings beat on membership growth, 2018 guidance pulled up.
Will Higher Revenues Aid UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
Continued strong performance across the company to aid UnitedHealth's (UNH) results.
Humana (HUM) Jointly Buys Curo, Boosts Medicare Business
by Zacks Equity Research
Humana (HUM) completes its joint acquisition of Curo with WCAS to expand its Medicare Advantage business.
UnitedHealth's Unit to Provide Better Care in North Carolina
by Zacks Equity Research
UnitedHealth's (UNH) arm forges an alliance with Community Care for providing better and cost-efficient care in North Carolina.
The Zacks Analyst Blog Highlights: Micron Technology, ArcBest, Marathon Oil, Azure Power Global and Molina Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Micron Technology, ArcBest, Marathon Oil, Azure Power Global and Molina Healthcare